"Change is part of life here – and that’s exciting. The nature and size of the business means we’re always looking for continuous improvement."

Charlotte Yates | Associate Director, Change Management

Inhalation is our focus. With more than 20 years’ experience, we help customers and partners succeed in bringing inhaled medicines to market. Customers choose us for our unique combination of inhalation development expertise, formulation science and device technology.

As an international community of scientists, engineers, regulatory specialists, quality managers and more, we working closely together to develop innovative, inhaled product development solutions that meet our customers’ needs and, ultimately, improve patients’ lives.

More about us Our services

Vectura at a glance

£160.5m

Annual reported
revenue in 2018

5

Sites around
the world

9m

Patients using products
based on Vectura’s
Intellectual Property in 2018

11

Inhaled in-market
medicines, launched
by our partners
and licensees

450+

People working
for Vectura

Our story

In just over 20 years, we’ve developed from a pharmaceutical start-up into an international company with world-leading inhalation capabilities. With global product development partnerships and an exciting new ambition to become a market-leading CDMO, we’re set for continued growth.

1997

Founded as a biotech company to commercialise respiratory pharmaceutical technologies originating from the University of Bath

1999

Merges with a research group from the University that has been developing PowderHale® technology

2002

Moves from University of Bath campus to Chippenham

2002

Vectura Delivery Devices created in Cambridge

2004

Floats on the London Stock Exchange Alternative Investment Market (AIM), raising £20.1m

2004

Vectura Delivery Devices moves to the Cambridge Science Park

2006

Buys Innovata Biomed, creating the UK's largest biotech company at the time

2009

Becomes a FTSE Top 250 company

2010

GlaxoSmithKline signs a collaboration agreement to use Vectura’s powder drug formulation

2012

Launches Ultibro® Breezhaler® with Novartis in the EU and Japan

2014

Acquires German pharmaceutical company Activaero for £108m

2015

Our engineering teams move to a new site on the Cambridge Science Park

2016

Merges with Skyepharma in a £440m deal

2018

Generic GSK Ellipta® deal signed with Hikma – the largest product deal in the Group’s history 

Our values

To enable us to help our customers bring their inhaled medicines to market we have a clear set of values that guide our decisions and actions.

Deliver for patients with pride
Create a great customer experience
Work together as one team
Do the right thing
Innovate and improve

We are agile, efficient and deliver our commitments. We take pride in successfully  developing medicines that transform lives.

Our customer focus guides everything we do. We use our insight and capability to create a great experience for our customers.

We collaborate to achieve shared goals, using our combined knowledge and expertise to enable success.

Quality is at the heart of everything we do. We work with integrity, consistently delivering to high standards.

We thrive on learning and apply our expertise to continually innovate and be the best at what we do.

Our future

Inhaled delivery is used to treat respiratory and non-respiratory diseases affecting millions of people around the world. At Vectura, we have the expertise and capability to help our customers and partners develop innovative inhaled products that can improve their lives.

That’s why we’re continuing to innovate, expanding our technical and scientific capabilities further. By recruiting adaptable, creative people who are committed to designing, developing and delivering ground-breaking solutions, we aim to delight customers and become a market-leading company in the inhalation CDMO space.

A responsible business

Supporting charity

We support Asthma UK as well as local charities in Germany and Switzerland. Our staff social committee organises a wide variety of events each year to raise funds and to create opportunities for our people to socialise and have fun together.

Our #V2V charity bike ride is a big annual event and since 2015 has raised more than £70,000 for worthy causes. Through our Charitable Support Policy, we also give colleagues time to support voluntary causes close to their hearts.

Quality Pharmaceutical

Our voluntary STEM Ambassadors work closely with schools and colleges to inspire young people, promoting learning and careers in Science, Technology, Engineering and Maths.
We also collaborate academically with local universities.  

Protecting the environment

We aim to be as energy efficient as possible and have installed LED lighting in our offices and light movement sensors in our car parks. We’re also replacing critical systems such as chillers with more energy-efficient alternatives.